⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MIRA News
MIRA Pharmaceuticals, Inc. Common Stock
MIRA Pharmaceuticals Reports Positive Unblinded Phase 1 Data for Ketamir-2
accessnewswire.com
MIRA
Form 8-K
sec.gov
MIRA
MIRA Pharmaceuticals Announces Acceptance of Peer-Reviewed SKNY-1 Manuscript Highlighting Oral Obesity and Nicotine Addiction Drug Candidate
accessnewswire.com
MIRA
Form 8-K
sec.gov
MIRA
Miracell Receives FDA 510(k) Clearance for SMART M-CELL PRP Concentration System and SMART M-CELL Bone Marrow Concentration System
prnewswire.com
MIRA
Form 8-K
sec.gov
MIRA
MIRA Pharmaceuticals Reports Mira-55 Shows No THC- or Rimonabant-Associated CNS Side Effects in Preclinical Studies
accessnewswire.com
MIRA
Cycle Syncing® Method is Clinically Shown to Reduce PMS Symptoms for 92% of participants in 60 days
prnewswire.com
MIRA
HI
MIRA Pharmaceuticals Completes Phase 1 Dosing of Ketamir-2
accessnewswire.com
MIRA
Form 8-K
sec.gov
MIRA